04.05.2011 • Newspolyvinyl butyral

Solutia Sees Business Opportunity In Tornado Aftermath

Specialty chemical maker Solutia hopes to sell more laminated window glass and other energy-efficient products in the aftermath of deadly U.S. Midwest tornado, its chief executive said.

The company is headquartered in St. Louis, Mo., where the city's Lambert International Airport closed briefly late last month after a tornado ripped off part of the roof and shattered windows.

"They certainly could have benefited from having a lot of Solutia's glass, because they got a lot of glass breakages associated with the wind," Chief Executive Jeffry Quinn told Reuters. "Solutia's (polyvinyl butyral) products would have prevented the shattering effect they would have had with a lot of the tempered glass."

The company's polyvinyl butyral materials are used as layers inside window glass.

Solutia posted a better-than-expected quarterly profit on Monday, though revenue fell short of Wall Street's forecast. Solutia's shares were down 3.4% at $25.37 in afternoon trading. The stock has gained 40.2% in the past 52 weeks.

The Japanese disasters have not affected Solutia's sales of Crystex, said Quinn, referring to an insoluble sulfur used for replacement tire and rubber parts.

"We're seeing extraordinary demand levels for Crystex in Asia," Quinn said.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.